-
ZEISS: Significant Growth in Revenue and Earnings
en-cphi.cn
May 12, 2017
The ZEISS Group had a very successful end to the first six months of fiscal year 2016/17 (ended 31 March) and saw its revenue rise by 10 percent to EUR 2.550 billion (1st half of 2015/16: EUR 2.322 billion).
-
Shire's fourth-quarter sales more than double, lifted by Baxalta
firstwordpharma
February 17, 2017
Shire's fourth-quarter revenue more than doubled year-over-year to $3.8 billion, in line with analyst estimates, boosted by the purchase of Baxalta, the company reported Thursday. Net income in the three-month period jumped 63 percent to $457 million.
-
NATCO Pharma posts consolidated revenue of Rs 685.13 cr in December quarter
financialexpress
February 15, 2017
In Q3FY17, sales/ income from operations were reported at Rs 7,683 crores, registering a growth of eight over same quarter last year.
-
Allergan's fourth-quarter revenue climbs 7 percent, boosted by Botox sales
firstwordpharma
February 09, 2017
Allergan announced Wednesday that fourth-quarter sales climbed 7.1 percent year-over-year to $3.9 billion, topping analyst estimates of $3.8 billion.
-
Johnson & Johnson's Q4 sales boosted by new drugs; annual guidance comes in below estimates
firstwordpharma
January 25, 2017
Johnson & Johnson announced Tuesday that fourth-quarter sales of prescription drugs rose 2.1 percent year-over-year to $8.2 billion, with growth driven by revenue from new products including Imbruvica, Darzalex and Xarelto.
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight July 2025
